{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:24:34Z","timestamp":1793744674462,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T00:00:00Z","timestamp":1330992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Child Psychiatry Hum Dev"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s10578-012-0292-3","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T23:14:01Z","timestamp":1330989241000},"page":"674-682","source":"Crossref","is-referenced-by-count":42,"title":["A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders"],"prefix":"10.1007","volume":"43","author":[{"given":"Elmira","family":"Hasanzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ghanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shams-Ali","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,6]]},"reference":[{"key":"292_CR1","volume-title":"American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders DSM IV-TR, 4th edn (Text Revision)","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders DSM IV-TR, 4th edn (Text Revision). American Psychiatric Press, Washington DC"},{"key":"292_CR2","first-page":"1","volume":"58","author":"Autism and Developmental Disabilities Monitoring Network Surveillance Year","year":"2006","unstructured":"Autism and Developmental Disabilities Monitoring Network Surveillance Year (2006) Principal investigators; centers for disease control and prevention (CDC) (2009) Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, United States, 2006. MMWR Surveill Summ 58:1\u201320","journal-title":"MMWR Surveill Summ"},{"key":"292_CR3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00431-008-0764-4","volume":"167","author":"JG Steyaert","year":"2008","unstructured":"Steyaert JG, De la Marche W (2008) What\u2019s new in autism? Eur J Pediatr 167:1091\u20131101","journal-title":"Eur J Pediatr"},{"key":"292_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000079404","volume":"2","author":"S B\u00f6lte","year":"2003","unstructured":"B\u00f6lte S, Poustka F (2003) Genetic, environmental and immunologic factors in the etiology of autism spectrum disorders. Neuroembryology 2:175\u2013179","journal-title":"Neuroembryology"},{"key":"292_CR5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.nurt.2010.05.011","volume":"7","author":"S Bent","year":"2010","unstructured":"Bent S, Hendren RL (2010) Improving the prediction of response to therapy in autism. Neurotherapeutics 7:232\u2013240","journal-title":"Neurotherapeutics"},{"key":"292_CR6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/1547691X.2010.545086","volume":"8","author":"HV Ratajczak","year":"2011","unstructured":"Ratajczak HV (2011) Theoretical aspects of autism: causes\u2014a review. J Immunotoxicol 8:68\u201379","journal-title":"J Immunotoxicol"},{"key":"292_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157488507780619095","volume":"2","author":"MR Mohammadi","year":"2007","unstructured":"Mohammadi MR, Akhondzadeh S (2007) Autism spectrum disorders: etiology and pharmacotherapy. Current Drug Therapy 2:97\u2013103","journal-title":"Current Drug Therapy"},{"key":"292_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10673220802075852","volume":"16","author":"TJ Leskovec","year":"2008","unstructured":"Leskovec TJ, Rowles BM, Findling RL (2008) Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harv Rev Psychiatry 16:97\u2013112","journal-title":"Harv Rev Psychiatry"},{"key":"292_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pedhc.2008.12.001","volume":"23","author":"L West","year":"2009","unstructured":"West L, Waldrop J, Brunssen S (2009) Pharmacologic treatment for the core deceits and associated symptoms of autism in children. J Pediatr Health Care 23:75\u201389","journal-title":"J Pediatr Health Care"},{"key":"292_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/phe.10.45","volume":"4","author":"K Blankenship","year":"2010","unstructured":"Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ (2010) Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6\u201317\u00a0years. Ped Health 4:375\u2013381","journal-title":"Ped Health"},{"key":"292_CR11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.chc.2008.06.004","volume":"17","author":"SE Levy","year":"2008","unstructured":"Levy SE, Hyman SL (2008) Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatry Clin N Am 17:803\u2013820","journal-title":"Child Adolesc Psychiatry Clin N Am"},{"key":"292_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nurt.2010.05.002","volume":"7","author":"RS Akins","year":"2010","unstructured":"Akins RS, Angkustsiri K, Hansen RL (2010) Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics 7:307\u2013319","journal-title":"Neurotherapeutics"},{"key":"292_CR13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10803-006-0192-0","volume":"37","author":"E Hanson","year":"2007","unstructured":"Hanson E, Kalish LA, Bunce E, Curtis C, McDaniel S, Ware J, Petry J (2007) Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J Autism Dev Disord 37:628\u2013636","journal-title":"J Autism Dev Disord"},{"key":"292_CR14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/appi.ps.51.9.1130","volume":"51","author":"G Beaubrun","year":"2000","unstructured":"Beaubrun G, Gray GE (2000) A review of herbal medicines for psychiatric disorders. Psychiatry Serv 51:1130\u20131134","journal-title":"Psychiatry Serv"},{"key":"292_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0301-0082(02)00015-1","volume":"67","author":"KM Maclennan","year":"2002","unstructured":"Maclennan KM, Darlington CL, Smith PF (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67:235\u2013257","journal-title":"Prog Neurobiol"},{"key":"292_CR16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ptr.2778","volume":"23","author":"H Niederhofer","year":"2009","unstructured":"Niederhofer H (2009) First preliminary results of an observation of Ginkgo biloba treating patients with autistic disorder. Phytother Res 23:1645\u20131646","journal-title":"Phytother Res"},{"key":"292_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1389450003349380","volume":"1","author":"FV DeFeudis","year":"2000","unstructured":"DeFeudis FV, Drieu K (2000) Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1:25\u201358","journal-title":"Curr Drug Targets"},{"key":"292_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2710.1999.00231.x","volume":"24","author":"S Akhondzadeh","year":"1999","unstructured":"Akhondzadeh S (1999) Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther 24:241\u2013248","journal-title":"J Clin Pharm Ther"},{"key":"292_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10578-007-0084-3","volume":"39","author":"S Akhondzadeh","year":"2008","unstructured":"Akhondzadeh S, Tajdar H, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Shabstari OL, Ghelichnia HA (2008) A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. Child Psychiatry Hum Dev 39:237\u2013245","journal-title":"Child Psychiatry Hum Dev"},{"key":"292_CR20","first-page":"391","volume":"34","author":"TM Itil","year":"1998","unstructured":"Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ (1998) The pharmacological effects of Ginkgo Biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacol Bull 34:391\u2013397","journal-title":"Psychopharmacol Bull"},{"key":"292_CR21","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ (1985) The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 89:485\u2013491","journal-title":"Am J Ment Defic"},{"key":"292_CR22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659\u2013685","journal-title":"J Autism Dev Disord"},{"key":"292_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2710.2004.00546.x","volume":"29","author":"S Akhondzadeh","year":"2004","unstructured":"Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT (2004) Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. J Clin Pharm Ther 29:145\u2013150","journal-title":"J Clin Pharm Ther"},{"key":"292_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pnpbp.2009.09.012","volume":"34","author":"S Akhondzadeh","year":"2010","unstructured":"Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S (2010) Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Prog Neuropsychopharmacol Biol Psychiatry 34:32\u201336","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"292_CR25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.pnpbp.2010.07.005","volume":"34","author":"V Rezaei","year":"2010","unstructured":"Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S (2010) Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:1269\u20131272","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Child Psychiatry & Human Development"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10578-012-0292-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10578-012-0292-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10578-012-0292-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:16:24Z","timestamp":1559240184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10578-012-0292-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,6]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1007\/s10578-012-0292-3","relation":{},"ISSN":["0009-398X","1573-3327"],"issn-type":[{"value":"0009-398X","type":"print"},{"value":"1573-3327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,6]]}}}